ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology.

Saved in:
Bibliographic Details
Title: ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology.
Authors: Gawish R; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Starkl P; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Pimenov L; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Hladik A; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Lakovits K; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Oberndorfer F; Department of Pathology, Medical University of Vienna, Vienna, Austria., Cronin SJ; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Ohradanova-Repic A; Molecular Immunology Unit, Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Wirnsberger G; Aperion Biologics, Vienna, Austria., Agerer B; CeMM, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Endler L; CeMM, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Capraz T; Institute of Molecular Modeling and Simulation, Department of Material Sciences and Process Engineering, University of Natural Resources and Life Sciences, Vienna, Austria., Perthold JW; Institute of Molecular Modeling and Simulation, Department of Material Sciences and Process Engineering, University of Natural Resources and Life Sciences, Vienna, Austria., Cikes D; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Koglgruber R; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Hagelkruys A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Montserrat N; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Technology (BIST), Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina, Madrid, Spain., Mirazimi A; Karolinska Institute and Karolinska University Hospital, Department of Laboratory Medicine, Unit of Clinical Microbiology, Stockholm, Sweden.; National Veterinary Institute, Uppsala, Sweden., Boon L; Polpharma Biologics, Utrecht, Netherlands., Stockinger H; Molecular Immunology Unit, Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Bergthaler A; CeMM, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Oostenbrink C; Institute of Molecular Modeling and Simulation, Department of Material Sciences and Process Engineering, University of Natural Resources and Life Sciences, Vienna, Austria., Penninger JM; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada., Knapp S; Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Source: ELife [Elife] 2022 Jan 13; Vol. 11. Date of Electronic Publication: 2022 Jan 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2050-084X
DOI:10.7554/eLife.74623